Lucem Health Announces Innovation Collaborative with First Ascent, bringing AI to the front lines
for cancer patients
Your personalized therapy plan delivered in two weeks.
We put YOU at the center of your care
Cancer is not one disease. It is millions of diseases based on each patient's unique biology. That's why so many cancer treatments do not work. Even today, with all the new treatments, including DNA testing, 1 in 3 patients are still not helped by the standard of care and run out of treatment options.
Our approach puts YOU at the center of your treatment & finds the right combination of FDA-approved drugs unique to you. Your data defines your best treatment, improving outcomes for you. Our AI uncovers every weakness in your cancer.
Our next milestone is to make this platform available to all patients and their Doctors by September 2023.
From over a thousand approved drugs, we select hundreds based on your cancer type.
We test those drugs to see which ones kill your cancer cells.
We execute state of the art sequencing and use your full DNA & RNA.
Our AI engine reveals the underlying weaknesses in your cancer.
Helping oncologists improve patient care
First Ascent provides all the data and analysis to help select the right combination of FDA-approved agents that best target your patient’s cancer.
Our approach highlights each cancer’s vulnerabilities and broadens the scope of treatments possible for your patient.
Get started with us in
four simple steps!
Partners, Trials and Info
Read the latest to learn more about how First Ascent Biomedical is changing cancer care